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and appropriate management of ischemia/reperfusion 
injury.[3] With specific relevance to the microcirculation, 
it has been clearly demonstrated that evolution of 
hypercholesterolemia is associated with endothelial 
cell dysfunction.[3] In addition, it has been shown 
that there is a near abrogation in vascular nitric oxide 
bioavailability, elevated oxidant stress, and the creation 
of a strongly proinflammatory condition; symptoms 
which can culminate in profound impairments to vascular 
reactivity.[4] Researches in vascular consequences of 
chronic hypercholesterolemia, the mechanisms through 
which these consequences occur, and the potentially 
beneficial effects of ameliorative therapies have received 
considerable attention in recent years.[5-7]
In this regard, tending to use herbal medicine not only 
in the treatment and preventing various diseases,[8-10] but 
also in preventing the toxic effects of other drugs[11-13] has 
dramatically increased, especially in Iran. Fortunately, 
recent researches in the field of medicinal plants have 
had promising results,[2,14-19] although they may have 
significant side effects, too.[20-24] Dill (Anethum graveolens) 
is one of these plants which is also known as shevid and 
is sometimes used with rice and called shevid-polo.[25,26] 
It is the sole species of the genus Anethum. Dill usually 
INTRODUCTION
Cardiovascular diseases are the leading causes 
of morbidity and mortality all over the world. 
Hypercholesterolemia, especially elevated low-density 
lipoprotein (LDL), is a major coronary heart disease 
risk factor. While the American Heart Association 
<200 mg/dl recommended for cholesterol,[1] 16% of 
adults were found to have more than 240 mg/dl, a level 
considered to carry twice the cardiovascular risk of 
those individuals at the desired level.[1] Elevated LDL 
cholesterol and triglycerides are considered detrimental 
of cardiovascular outcomes. It has been suggested that 
very LDL and chylomicron remnants might also play 
an active role in peripheral vascular and coronary 
artery disease development.[2] Therefore, considerable 
attention has been directed toward examining the impact 
of cholesterol lowering medications and interventions 
for cardiovascular outcomes.[2]
Cholesterol has been shown to interrupt and alter vascular 
function and structure as it builds within the lining of the 
vascular wall, and is able to interfere with endothelial 
function leading to plaques, lesions, occlusion, and 
emboli; along with a reduction in recovery, healing, 
Background: It has been established that hyperlipidemia increases the incidence and mortality associated with coronary heart disease. 
In this study, the effects of Dill (Anethum graveolens) were evaluated on lipid profile of hypercholesterolemic patients. Materials 
and Methods: In this clinical study, 91 hyperlipidemic patients were randomly designated into two groups. One group received 
gemfibrozil (900 mg daily) and the other group received Dill tablet (six tablets daily) for 2 months. The blood lipids including total 
cholesterol, triglyceride and high density lipoprotein (HDL)-cholesterol from each group were assessed at the beginning and end 
of the trial. Results: Use of gemfibrozil brought about increased HDL-cholesterol by 3.91% (P < 0.05) and reduced triglyceride and 
total cholesterol by 32.7% (P < 0.05) and 9.41% (P < 0.05), respectively. Applying Dill tablet for 2 months resulted in reduction of 
total cholesterol up to 18% (P < 0.05) and triglyceride by 7.38% (P < 0.05). However, circulating HDL-cholesterol was not affected 
by this treatment. In this study, gemfibrozil decreased triglyceride and increased HDL-cholesterol more than anethum (P < 0.05). 
Anethum decreased total cholesterol more than gemfibrozil (P < 0.05). Patients treated with anethum did not report any side effects. 
Conclusion: The results of this trial indicate that Dill might be beneficial for hypercholesterolemic and hypertriglycemic patients.
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grows to 40-60 cm, with slender stems, finely divided, softly 
delicate leaves. The flowers are white to yellow, in small 
umbels 2-9 cm diameter.[26] Dill has a very long history of 
herbal use going back more than 2000 years. The seeds are 
a common and very effective household remedy for a wide 
range of digestive problems. The dill is useful as aromatic, 
carminative, mildly diuretic, galactogogue, stimulant and 
stomachic. It is also used to increase the flow of milk in 
nursing mothers, to help prevent colic, for bad breath, 
cough, cold and flu, period pains.[27-29]
Many people in Iran believe it can alleviate hyperlipidemia. 
According to an animal study, it has been shown to reduce 
postprandial heperglycemia and hypercholesterolemia in 
rabbit.[30] However, its impact on these parameters in human 
has not been studied, yet. This study was, therefore, designed 
to evaluate the Dill effects in comparison to gemfibrozil on 
lipid profile of hypercholesterolemic patients.
MATERIALS AND METHODS
This randomized single blind clinical study was performed 
on referring individuals to internal clinic, in Shahrekord 
University of Medical Sciences. The blood test was taken 
from patients after taking written consent and completing 
questionnaire by the colleague physician. Subjects in both 
groups using gemfibrozil and Dill were asked about age, 
gender, job (housekeeper, unemployed, and practitioner), 
the degree (illiterate, elementary education, diploma, 
bachelor or higher), body mass index (BMI), and related 
risk factors such as risk of hypertension and diabetes, 
smoking, having heart disease, heart disease history or 
hyperlipidemia in family (to take blood test, participants 
were asked to keep themselves fasting between 10 h and 
14 h (6 pm-8 am). During this time, they were free to drink 
water or tea. Then they referred to reference laboratory to 
take test in the morning. Total cholesterol and high density 
lipoprotein (HDL) were measured with cholesterol oxidase-
phosphatidic acid phosphatase (PAP) enzyme approach 
and triglycerides with glycerol phosphate oxidase-PAP 
enzyme approach, and spectrophotometric in 520 nm 
wavelength, according to kit instructions. Because in cases 
that triglyceride is more than 400 mg/dl, Friedewald formula 
cannot be used to measure LDL[27] and with regarding to 
this problem that in this study, great numbers of patients 
had triglyceride more than 400 mg/dl, it was skipped to 
measure and investigate LDL. After doing primary test, 
patients who had serum triglyceride between 250 and 
400 mg/dl, and serum total cholesterol between 220 and 
27  mg/dl and had not used drugs during the past month 
were invited to participate.
The hyperlipidemic patients with normal fasting glucose 
levels, normal kidney, liver and thyroid functions included 
the trial. Patients with coronary artery disease, diabetes, 
hypertension, or obesity were excluded from the study. No 
patient was allowed to use lipid-modifying drugs, diuretics, 
beta-blockers, corticosteroids, and sex steroids.
Ninety ones who met the above requirements, willing to 
cooperate were placed equally in groups A and B based 
on the entrance time, so that, the first patient was assigned 
to group one and the second one to group two, and so on. 
Group A was given gemfibrozil (Darupakhsh, Iran), 900 mg 
orally/day,[31] and group B was given Dill tablets (six pills 
a day, Iran Daruk, Iran) for 2 months. The Dill dose was 
chosen based on traditional use of this plant by Iranian 
people. Patients were asked to record and report any side 
effects. Blood lipid testing was repeated again at the end 
of the treatment period. After completing questionnaires 
and laboratory results, data were compared by paired t-test 
using, IBM SPSS Statistics version 21, USA.
Data were analyzed by paired t-test for comparison of each 
factor before and after treatment and Student’s t-test for 
comparison of the each factor between groups, using SPSS 
software version.
RESULTS
A total of 13 patients were excluded from the study due to 
incompliance, so that 42 patients in gemfibrozil group and 
35 ones in Dill group completed the study. These patients 
were taken a test at the end of the study [Figure 1]. People 
in both treatment groups of gemfibrozil and Dill were 
compared according to age, gender, BMI, smoking, having 
diabetes, hypertension and heart disease that there was no 
significant difference between them. Furthermore, there was 
no significant difference between two groups for cholesterol, 
triglyceride or HDL before treatment [Table 1]. In Dill group 
21% and in gemfibrozil group 34% of patients observed 
low-fat diet. As Table 2 shows, the mean level of cholesterol 
Figure 1: Flow diagram of the progress through the phases of parallel randomized 
trial of two groups
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and triglyceride has been reduced in comparison to before 
treatment after treating with gemfibrozil (P < 0.001). Also, in 
Dill group, the mean level of cholesterol and triglyceride has 
been reduced in comparison to before treatment (P < 0.001) 
but there was not a significant difference between the mean 
level of HDL in Dill group, before and after treatment 
[Table 3].
By using Dill, the mean level of cholesterol was reduced 
by 18%, and by using gemfibrozil, it was reduced by 9.41% 
(P < 0.05). Gemfibrozil and Dill has reduced triglyceride 
by 32.7% and 7.38%, respectively (P < 0.05). Gemfibrozil 
has increased HDL by 3.91%, but Dill reduced it by 0.8% 
(P < 0.05) [Table 2].
By using Dill, patients did not express any signs of adverse 
effects. However, 21.4% of patients who used gemfibrozil 
reported gastrointestinal complications.
DISCUSSION
In this study, results showed that Dill had less impact on 
triglyceride and HDL in comparison to gemfibrozil but 
reduced cholesterol more. Dill impact on reducing patients’ 
cholesterol was statistically significant in comparison to 
gemfibrozil. However, it should be considered that gemfibrozil 
has been known as an effective drug on triglyceride, and in 
previous studies gemfibrozil had little impact on cholesterol. 
On the other hand, cholesterol average in patients pre-treated 
with Dill is nearly equal to normal maximum (240 mg/dg).
In a study that has been done on hyperlipidemic patients, Dill 
effect has been compared with cholestyramine, nicotinic acid, 
and placebo that Dill has not statistically had a significant 
difference with placebo in reducing cholesterol and triglyceride 
and it had not been effective in comparison to other known 
drugs.[27] The only other independent research that has shown 
appropriate effect of Dill on hyperlipidemia is the study that 
Institute of biochemistry and biophysics, Tehran University, 
has studied the essence of Dill leave on blood lipids in rat.[32]
It is not clear that with what mechanism Dill plant is 
effective on hyperlipidemia, but in other studies done on 
the impact of several volatile compounds it has been shown 
that antioxidants are the main reason for hypolipidemic and 
antitoxic activities of these plants.[33-36]
According to the above study and inconsistent results for 
an exact comment about the Dill drug, it seems that doing 
more comprehensive studies on Dill effect on blood lipids 
and their mechanism are required. As mentioned in the 
result section, no side effect was reported. In examining 
gemfibrozil effects, patients just mentioned gastrointestinal 
complications and because of time limitation, it was not 
possible to investigate other effects of gemfibrozil like 
increased risk of gallstones, myopathy, and so on.
Totally, according to the limited effects of Dill and good 
impact of this drug on cholesterol and blood triglyceride, 
it seems that Dill is an appropriate drug for treating 
hyperlipidemia and triglyceride.
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Table 1: Comparison of cholesterol, triglyceride and 
HDL average in two groups
Groups Cholesterol Triglyceride HDL
Before treatment
Gemfibrozil 234.76±9.4 343.73±30.2 47.33±8.8
Dill 260.71±6.77 389.82±13.6 48.14±9.1
P value >0.05 >0.05 >0.05
After treatment
Gemfibrozil 212.66±7.7 287.54±19.4 49.26±8.5
Dill 213.71±9.67 309.37±13.01 47.74±8.7
P value >0.05 >0.05 >0.05
The results are presented as mean ± SD; HDL = High density lipoprotein; SD = Standard 
deviation
Table 2: Comparison of cholesterol, triglyceride and 
HDL average before and after treatment with gemfibrozil
Variables Groups Amount 
of 
changes
P value
Before 
treating with 
gemfibrozil
After 
treating with 
gemfibrozil
Cholesterol (mg/dl) 234.76±9.4 212.66±7.7 22.10±1.7 0.001
HDL (mg/dl) 47.33±8.8 49.26±8.5 2.26±3.9 0.004
Triglyceride (mg/dl) 343.73±30.2 287.54±19.4 56±10.8 0.001
The results are presented as mean ± SD; HDL = High density lipoprotein; SD = Standard 
deviation
Table 3: Comparison of cholesterol, triglyceride and 
HDL average before and after treatment with Dill
Variables Groups Amount of 
changes
P value
Before treating 
with Dill
After treating 
with Dill
Cholesterol 
(mg/dl)
260.71±6.77 213.71±9.67 47.0±2.9 0.001
HDL (mg/dl) 48.14±9.1 47.74±8.7 0.4±6.5 0.721
Triglyceride 
(mg/dl)
389.82±13.6 309.37±13.01 89.45±0.50 0.001
The results are presented as mean ± SD; HDL = High density lipoprotein; SD = Standard 
deviation
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